All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Security
Security
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

A doctor reconsiders the Midjourney ultrasound scanner's potential for accessible screening

By

Matthew Zirwas, MD

14h ago· 2 min readenOpinion

Summary

A doctor reflects on being wrong about the potential value of the Midjourney ultrasound scanner. The author initially dismissed widespread screening imaging based on historical precedent showing it's net neutral or harmful. However, they now realize that those precedents were based on imaging that was expensive, inconvenient, physician-gated, and not easily repeatable. If the Midjourney ultrasound is high-resolution, harmless, inexpensive, and convenient, it could change the calculus entirely by allowing frequent, accessible screening.

Source

Hacker NewsA doctor reconsiders the Midjourney ultrasound scanner's potential for accessible screeningtwitter.com

Key quotes

· 4 pulled
I was wrong about the Midjourney ultra-sound scanner.
I missed something obvious because I was thinking like a doctor who's been practicing for 25 years.
All historical precedent that showed that widespread screening imaging is net neutral or harmful was imaging that was expensive, inconvenient, gated by physicians and couldn't practically be repeated frequently short term.
If the Midjourney ultrasound is high resolution, harmless, inexpensive and convenient, people can get an initial sc
Snippet from the RSS feed
I was wrong about the Midjourney ultra-sound scanner. Well, maybe not wrong, but at a minimum I missed something obvious because I was thinking like a doctor who's been practicing for 25 years. And I didn't explain my point well. First, where I was wro

You might also wanna read

Comments

Sign in to join the conversation.

No comments yet. Be the first.